Opinion|Videos|April 11, 2025
Managing Safety and Quality of Life With Cemiplimab in Advanced NSCLC
Author(s)Eric K. Singhi, M.D., Ben Creelan, M.D.
Panelists discuss how balancing survival benefits with quality of life involves careful monitoring of treatment-related adverse effects. Managing immune-related adverse events in patients on immune checkpoint inhibitors like cemiplimab requires early detection, timely intervention and proactive strategies to minimize impact on outcomes.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- How are potential survival benefits balanced with impacts on patients’ quality of life, particularly in the context of treatment-related adverse effects?
- How do you approach the management of immune-related adverse events in patients receiving immune checkpoint inhibitors like cemiplimab?
- What proactive strategies do you use to minimize the impact of treatment-related adverse events on patient outcomes?
Advertisement
Related to this article
The rule requires pharmacy benefit managers to disclose rebates and discounts, money made from spread pricing and incentives for formulary placement.
As pulmonary fibrosis treatment options grow, Rachael Prusi of Prime Therapeutics says health plans should lean on guidelines and strong case management.
Patients with pulmonary fibrosis wait about two years for a diagnosis. Rachael Prusi of Prime Therapeutics explains how health plans can find them sooner.
The FDA has approved three HIV products since June 2025, and the late-stage pipeline is testing how far apart doses can be spaced. Here are the milestones payers and health systems should track through 2027.
Hiva Pourarsalan at AMCP Nexus explains how MFP shifts Medicare drug pricing, disrupting rebates and contracting and forcing payers to rethink formularies.
EHRs miss many cancer deaths. Linking electronic health records with claims and third‑party death data sharply improves accuracy, Tempus reports at AMCP Nexus.
CMS projects roughly 2.3 million people will lose Medicaid coverage in 2027 under the new community engagement requirements, also referred to as work requirements: four in ten to paperwork, not noncompliance. Arkansas showed how that happens; here is what plans can learn before the clock starts.
Managed care leaders should vet AI tools before use and recheck them over time, and pharmacists need AI literacy, according to two AMCP Nexus 2026 presenters.
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
5 things you should know about the midterms and healthcare
2
Prime's Pat Gleason flags cost, timing gaps in type 1 diabetes screening | AMCP Nexus 2026
3
2.3 million reasons to rethink member communications before Jan. 1
4
5 things you should know about intismeran, the Moderna-Merck cancer vaccine
5